Alzamend Neuro

ALZN58

High Growth

$1.75arrow_drop_up1.15%$0.02

High Growth

Penny Stock

ALZN58

$1.75

arrow_drop_up1.15%$0.02

High Growth

Penny Stock

Performance History

Key Stats
Open	$1.76
Prev. Close	$1.73
EPS	-142.87
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$7.10M
PE Ratio	-

	LOW	HIGH
Day Range	1.70	1.82
52 Week Range	1.60	39.00

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-142.87

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Alzamend Neuro (ALZN)

Alzamend Neuro, Inc. (ALZN) is a biopharmaceutical company focused on developing innovative therapies for the treatment of Alzheimer's disease. With a mission to improve the lives of those affected by this devastating neurodegenerative disease, ALZN is dedicated to finding solutions to one of the greatest healthcare challenges of our time. The company's primary focus is on developing novel therapeutic drug candidates that target the underlying mechanisms of Alzheimer's disease, with the ultimate goal of slowing or halting disease progression. ALZN's research and development efforts are backed by a team of leading experts in the field of neurology and Alzheimer's disease.

As of the latest available information, the stock price of Alzamend Neuro, Inc. (ALZN) is not provided. It is recommended to check reliable financial sources for the most up-to-date stock price. ALZN is a publicly traded company, and its stock price can be influenced by various factors, including market conditions, company performance, and investor sentiment.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Stephan Jackman
Headquarters: Atlanta
Employees: 4
Exchange: NASDAQ

Keep an eye on Alzamend Neuro

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Alzamend Neuro's (ALZN) price per share?

The current price per share for Alzamend Neuro (ALZN) is $1.75. The stock has seen a price change of $0.02 recently, indicating a 1.16% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Alzamend Neuro (ALZN)?

For Alzamend Neuro (ALZN), the 52-week high is $39, which is 2.13K% from the current price. The 52-week low is $1.6, the current price is 9.38% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Alzamend Neuro (ALZN) a growth stock?

Alzamend Neuro (ALZN) has shown an average price growth of 0.41% over the past three years. It has received a score of 42 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Alzamend Neuro as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Alzamend Neuro (ALZN) stock price performance year to date (YTD)?

As of the latest data, Alzamend Neuro (ALZN) has a year-to-date price change of -80.98%. Over the past month, the stock has experienced a price change of -70.09%. Over the last three months, the change has been -56.14%. Over the past six months, the figure is -81.96%.

help

Is Alzamend Neuro (ALZN) a profitable company?

Alzamend Neuro (ALZN) has a net income of -$9.95M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$9.94M. Furthermore, the EBITDA is -$9.89M.

help

What is the market capitalization of Alzamend Neuro (ALZN)?

Alzamend Neuro (ALZN) has a market capitalization of $7.1M. The average daily trading volume is 340.28K, indicating the stock's liquidity and investor engagement.